RecruitingNot ApplicableNCT04787848

Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics

Role of Endogenous Opioid Peptides in HIV-associated Chronic Widespread Pain


Sponsor

Florida International University

Enrollment

200 participants

Start Date

Nov 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV


Eligibility

Min Age: 19 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at chronic widespread pain in people living with HIV, to better understand what causes it and whether existing treatments can help. Many people with HIV experience persistent pain throughout their body, but it is not well understood. Researchers are enrolling both HIV-positive and HIV-negative participants for comparison. **You may be eligible if...** - You are between 19 and 65 years old - You have a confirmed HIV diagnosis and are currently receiving stable HIV treatment (antiretroviral therapy), OR - You are confirmed HIV-negative (for comparison group) - You are a current patient at the UAB 1917 HIV Clinic (for HIV-positive participants) **You may NOT be eligible if...** - You are under 19 or over 65 - You are HIV-positive but not currently on stable antiretroviral treatment - You have other health conditions that meet the study's exclusion criteria Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRelistor Injectable Product

Relistor is a peripherally acting opioid receptor antagonist approved by the FDA for relief of opioid-induced constipation


Locations(1)

Ambulatory Care Center, Florida International University

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04787848


Related Trials